TIL Instil Bio delivers strong Q4 2025 EPS upside versus analyst estimates shares edge slightly higher in todays session VNTG Vantage posts 67 percent year over year Q2 2025 revenue decline shares rise 242 percent Equus EQS Stock Why Technology Adoption Investor Concern 20260422 The one question every Immuneering Corporation IMRX investor should ask Smart Money Flows 20260511 Union Pacific Corporation UNP Positioning Amid 2026 TechDriven Market Rotation Dynamics